Literature DB >> 19204775

The cost-benefit ratio of screening pregnant women for thrombophilia.

Gian Luca Salvagno1, Giuseppe Lippi, Massimo Franchini, Giovanni Targher, Martina Montagnana, Massimo Franchi, Gian Cesare Guidi.   

Abstract

Entities:  

Keywords:  abortion; complications; pregnancy; screening; thrombophilia

Year:  2007        PMID： 19204775      PMCID： PMC2581909          DOI： 10.2450/2007.0022-07

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  205 in total

1.  Failure of thromboprophylaxis in pregnancy caused by dual deficiencies of protein S and protein C.

Authors:  Mamoru Morikawa; Hideto Yamada; Emi H Kato; Shinichiro Wada; Shigenori Suzuki; Noriaki Sakuragi; Hisanori Minakami
Journal:  Semin Thromb Hemost       Date:  2005-06       Impact factor: 4.180

2.  Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples.

Authors:  B L Soderberg; E T Sicinska; E Blodget; J E Cluette-Brown; P M Suter; T Schuppisser; W Vetter; M Laposata
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

Review 3.  von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.

Authors:  Ida Martinelli
Journal:  Semin Hematol       Date:  2005-01       Impact factor: 3.851

4.  Preeclampsia and genetic risk factors for thrombosis: a case-control study.

Authors:  C J De Groot; K W Bloemenkamp; E J Duvekot; F M Helmerhorst; R M Bertina; F Van Der Meer; H De Ronde; S G Oei; H H Kanhai; F R Rosendaal
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

5.  Mutations in coagulation factors in women with unexplained late fetal loss.

Authors:  I Martinelli; E Taioli; I Cetin; A Marinoni; S Gerosa; M V Villa; M Bozzo; P M Mannucci
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

6.  Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.

Authors:  M Hallak; J Senderowicz; A Cassel; C Shapira; E Aghai; R Auslender; H Abramovici
Journal:  Am J Obstet Gynecol       Date:  1997-04       Impact factor: 8.661

7.  Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications.

Authors:  M J Paidas; D-H W Ku; M-J Lee; S Manish; A Thurston; C J Lockwood; Y S Arkel
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

8.  Hereditary thrombophilia and fetal loss: a prospective follow-up study.

Authors:  C Y Vossen; F E Preston; J Conard; J Fontcuberta; M Makris; F J M van der Meer; I Pabinger; G Palareti; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2004-04       Impact factor: 5.824

9.  Absence of association of thrombophilia polymorphisms with intrauterine growth restriction.

Authors:  Claire Infante-Rivard; Georges-Etienne Rivard; Wagner V Yotov; Emmanuelle Génin; Marguerite Guiguet; Clarice Weinberg; Robert Gauthier; Juan Carlos Feoli-Fonseca
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

10.  A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis.

Authors:  M C de Visser; F R Rosendaal; R M Bertina
Journal:  Blood       Date:  1999-02-15       Impact factor: 22.113
View more
  2 in total

Review 1.  'To test or not to test', the arguments for and against thrombophilia testing in obstetrics.

Authors:  Laura Ormesher; Louise E Simcox; Clare Tower; Ian A Greer
Journal:  Obstet Med       Date:  2017-03-08

2.  Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene.

Authors:  Minyoung Kong; Younyoung Kim; Chaeyoung Lee
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.